These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 28539530)

  • 1. Active form of vitamin D ameliorates non-alcoholic fatty liver disease by alleviating oxidative stress in a high-fat diet rat model.
    Zhu CG; Liu YX; Wang H; Wang BP; Qu HQ; Wang BL; Zhu M
    Endocr J; 2017 Jul; 64(7):663-673. PubMed ID: 28539530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hesperetin ameliorates hepatic oxidative stress and inflammation
    Li J; Wang T; Liu P; Yang F; Wang X; Zheng W; Sun W
    Food Funct; 2021 May; 12(9):3898-3918. PubMed ID: 33977953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin D attenuates high fat diet-induced hepatic steatosis in rats by modulating lipid metabolism.
    Yin Y; Yu Z; Xia M; Luo X; Lu X; Ling W
    Eur J Clin Invest; 2012 Nov; 42(11):1189-96. PubMed ID: 22958216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salidroside alleviates oxidative stress in the liver with non- alcoholic steatohepatitis in rats.
    Yang ZR; Wang HF; Zuo TC; Guan LL; Dai N
    BMC Pharmacol Toxicol; 2016 Apr; 17():16. PubMed ID: 27075663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exendin-4, a glucagon-like peptide-1 receptor agonist downregulates hepatic receptor for advanced glycation end products in non-alcoholic steatohepatitis rat model.
    Allam MM; El Gazzar WB
    Arch Physiol Biochem; 2018 Feb; 124(1):10-17. PubMed ID: 28696785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regressive Effect of Myricetin on Hepatic Steatosis in Mice Fed a High-Fat Diet.
    Xia SF; Le GW; Wang P; Qiu YY; Jiang YY; Tang X
    Nutrients; 2016 Dec; 8(12):. PubMed ID: 27973423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoic Acid Prevents High-Fat Diet-Induced Hepatic Steatosis in Goto Kakizaki Rats by Reducing Oxidative Stress Through Nrf2 Activation.
    Sena CM; Cipriano MA; Botelho MF; Seiça RM
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30208622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1,25(OH)2D3 downregulates the Toll-like receptor 4-mediated inflammatory pathway and ameliorates liver injury in diabetic rats.
    Wang H; Zhang Q; Chai Y; Liu Y; Li F; Wang B; Zhu C; Cui J; Qu H; Zhu M
    J Endocrinol Invest; 2015 Oct; 38(10):1083-91. PubMed ID: 25906757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scutellarin Prevents Nonalcoholic Fatty Liver Disease (NAFLD) and Hyperlipidemia via PI3K/AKT-Dependent Activation of Nuclear Factor (Erythroid-Derived 2)-Like 2 (Nrf2) in Rats.
    Fan H; Ma X; Lin P; Kang Q; Zhao Z; Wang L; Sun D; Cheng J; Li Y
    Med Sci Monit; 2017 Nov; 23():5599-5612. PubMed ID: 29172017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary creatine supplementation lowers hepatic triacylglycerol by increasing lipoprotein secretion in rats fed high-fat diet.
    da Silva RP; Leonard KA; Jacobs RL
    J Nutr Biochem; 2017 Dec; 50():46-53. PubMed ID: 29031242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sugary Kefir Strain Lactobacillus mali APS1 Ameliorated Hepatic Steatosis by Regulation of SIRT-1/Nrf-2 and Gut Microbiota in Rats.
    Chen YT; Lin YC; Lin JS; Yang NS; Chen MJ
    Mol Nutr Food Res; 2018 Apr; 62(8):e1700903. PubMed ID: 29508520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental nonalcoholic fatty liver disease in mice leads to cytochrome p450 2a5 upregulation through nuclear factor erythroid 2-like 2 translocation.
    Cui Y; Wang Q; Li X; Zhang X
    Redox Biol; 2013; 1(1):433-40. PubMed ID: 24191237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Niga-ichigoside F1 ameliorates high-fat diet-induced hepatic steatosis in male mice by Nrf2 activation.
    Xia SF; Shao J; Zhao SY; Qiu YY; Teng LP; Huang W; Wang SS; Cheng XR; Jiang YY
    Food Funct; 2018 Feb; 9(2):906-916. PubMed ID: 29309075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caffeine affects HFD-induced hepatic steatosis by multifactorial intervention.
    Helal MG; Ayoub SE; Elkashefand WF; Ibrahim TM
    Hum Exp Toxicol; 2018 Sep; 37(9):983-990. PubMed ID: 29249184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chicoric Acid Ameliorates Nonalcoholic Fatty Liver Disease via the AMPK/Nrf2/NF
    Ding X; Jian T; Li J; Lv H; Tong B; Li J; Meng X; Ren B; Chen J
    Oxid Med Cell Longev; 2020; 2020():9734560. PubMed ID: 33204402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liraglutide Ameliorates Lipotoxicity-Induced Oxidative Stress by Activating the NRF2 Pathway in HepG2 Cells.
    Zhu CG; Luo Y; Wang H; Li JY; Yang J; Liu YX; Qu HQ; Wang BL; Zhu M
    Horm Metab Res; 2020 Jul; 52(7):532-539. PubMed ID: 32375182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1,2,3,4,6 penta-O-galloyl-β-D-glucose ameliorates high-fat diet-induced nonalcoholic fatty liver disease and maintains the expression of genes involved in lipid homeostasis in mice.
    Kant R; Lu CK; Nguyen HM; Hsiao HH; Chen CJ; Hsiao HP; Lin KJ; Fang CC; Yen CH
    Biomed Pharmacother; 2020 Sep; 129():110348. PubMed ID: 32554245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PSA controls hepatic lipid metabolism by regulating the NRF2 signaling pathway.
    Huang B; Xiong X; Zhang L; Liu X; Wang Y; Gong X; Sang Q; Lu Y; Qu H; Zheng H; Zheng Y
    J Mol Cell Biol; 2021 Oct; 13(7):527-539. PubMed ID: 34048566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apigenin, a modulator of PPARγ, attenuates HFD-induced NAFLD by regulating hepatocyte lipid metabolism and oxidative stress via Nrf2 activation.
    Feng X; Yu W; Li X; Zhou F; Zhang W; Shen Q; Li J; Zhang C; Shen P
    Biochem Pharmacol; 2017 Jul; 136():136-149. PubMed ID: 28414138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liensinine alleviates high fat diet (HFD)-induced non-alcoholic fatty liver disease (NAFLD) through suppressing oxidative stress and inflammation via regulating TAK1/AMPK signaling.
    Liang L; Ye S; Jiang R; Zhou X; Zhou J; Meng S
    Int Immunopharmacol; 2022 Mar; 104():108306. PubMed ID: 34999396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.